The Wisconsin Epidemiologic Study of Diabetic Retinopathy XXIII: The Twenty-five-Year Incidence of Macular Edema in Persons with Type 1 Diabetes

Ophthalmology

Volumn 116, Issue 3, 2009, Pages 497-503

  Klein, Ronald ^a   Knudtson, Michael D ^a   Lee, Kristine E ^a   Gangnon, Ronald ^a   Klein, Barbara E K ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN;

ADULT; ARTICLE; CHILD; DIABETIC MACULAR EDEMA; DIABETIC PATIENT; DIABETIC RETINOPATHY; DIASTOLIC BLOOD PRESSURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; EYE FUNDUS; EYE PHOTOGRAPHY; FEMALE; FOLLOW UP; GENDER; GLUCOSE BLOOD LEVEL; HUMAN; INCIDENCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; MORTALITY; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEINURIA; RISK FACTOR; SCHOOL CHILD; SMOKING; STEREOSCOPIC VISION; SYSTOLIC BLOOD PRESSURE; UNITED STATES;

ADOLESCENT; ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; EPIDEMIOLOGIC STUDIES; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INCIDENCE; INFANT; INFANT, NEWBORN; MACULAR EDEMA; MALE; PREVALENCE; RISK FACTORS; WISCONSIN;

EID: 61349121337     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2008.10.016     Document Type: Article

References (55)

1. Klein R., and Klein B.E. Vision disorders in diabetes. National Diabetes Data Group. Diabetes in America. 2nd ed. (1995), National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD 293-338 NIH Publication No. 95-1468
2. Tielsch J.A. Prevent Blindness America. Vision Problems in the U.S: A Report on Blindness and Vision Impairment in Adults Age 40 and Older (1995), Prevent Blindness America, Schaumburg, IL 1-20
3. Moss S.E., Klein R., and Klein B.E. Ten-year incidence of visual loss in a diabetic population. Ophthalmology 101 (1994) 1061-1070
4. Aiello L.M., Rand L.I., Briones J.C., et al. Diabetic retinopathy in Joslin Clinic patients with adult-onset diabetes. Ophthalmology 88 (1981) 619-623
5. Myers F.L., Davis M.D., and Magli Y.L. The natural course of diabetic retinopathy: a clinical study of 321 eyes followed one year or more. In: Goldberg M.F., and Fine S.L. (Eds). Symposium on the Treatment of Diabetic Retinopathy (1969), U.S. Neurological and Sensory Disease Control Program, Arlington, VA 81-85 PHS publication 1890
6. Kohner E.M. The evolution and natural history of diabetic retinopathy. Int Ophthalmol Clin 18 (1978) 1-16
7. Sigelman J. Diabetic macular edema in juvenile- and adult-onset diabetes. Am J Ophthalmol 90 (1980) 287-296
8. Klein R., Moss S.E., Klein B.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XI. The incidence of macular edema. Ophthalmology 96 (1989) 1501-1510
9. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XV. The long-term incidence of macular edema. Ophthalmology 102 (1995) 7-16
10. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XVII. The 14-year incidence and progression of diabetic retinopathy and associated risk factors in type 1 diabetes. Ophthalmology 105 (1998) 1801-1815
11. Vitale S., Maguire M.G., Murphy R.P., et al. Clinically significant macular edema in type I diabetes: incidence and risk factors. Ophthalmology 102 (1995) 1170-1176
12. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications Research Group. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. N Engl J Med 342 (2000) 381-389
13. Aroca P.R., Salvat M., Fernandez J., and Mendez I. Risk factors for diffuse and focal macular edema. J Diabetes Complications 18 (2004) 211-215
14. Williams R., Airey M., Baxter H., et al. Epidemiology of diabetic retinopathy and macular oedema: a systematic review. Eye 18 (2004) 963-983
15. Miljanovic B., Glynn R.J., Nathan D.M., et al. A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes 53 (2004) 2883-2892
16. Jaross N., Ryan P., and Newland H. Incidence and progression of diabetic retinopathy in an Aboriginal Australian population: results from the Katherine Region Diabetic Retinopathy Study (KRDRS). Report no. 2. Clin Experiment Ophthalmol 33 (2005) 26-33
17. Leske M.C., Wu S.Y., Hennis A., et al., Barbados Eye Study Group. Nine-year incidence of diabetic retinopathy in the Barbados Eye Studies. Arch Ophthalmol 124 (2006) 250-255
18. Rossing P. The changing epidemiology of diabetic microangiopathy in type 1 diabetes. Diabetologia 48 (2005) 1439-1444
19. Chase H.P., Lockspeiser T., Peery B., et al. The impact of the Diabetes Control and Complications Trial and Humalog insulin on glycohemoglobin levels and severe hypoglycemia in type 1 diabetes. Diabetes Care 24 (2001) 430-434
20. Hovind P., Tarnow L., Rossing K., et al. Decreasing incidence of severe diabetic microangiopathy in type 1 diabetes. Diabetes Care 26 (2003) 1258-1264
21. Hoerger T.J., Segel J.E., Gregg E.W., and Saaddine J.B. Is glycemic control improving in U.S. adults?. Diabetes Care 31 (2008) 81-86
22. Klein R., Klein B.E., Moss S.E., et al. Prevalence of diabetes mellitus in southern Wisconsin. Am J Epidemiol 119 (1984) 54-61
23. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 102 (1984) 520-526
24. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. III. Prevalence and risk of diabetic retinopathy when age at diagnosis is 30 or more years. Arch Ophthalmol 102 (1984) 527-532
25. Klein R., Klein B.E., Moss S.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. IX. Four-year incidence and progression of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol 107 (1989) 237-243
26. Klein R., Klein B.E., Moss S.E., and Cruickshanks K.J. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol 112 (1994) 1217-1228
27. Klein B.E., Klein R., McBride P.E., et al. Cardiovascular disease, mortality, and retinal microvascular characteristics in type 1 diabetes: Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 164 (2004) 1917-1924
28. Klein R., Knudtson M.D., Lee K.E., et al. The Wisconsin Epidemiologic Study of Diabetic Retinopathy. XXII. The twenty-five-year progression of retinopathy with persons with type 1 diabetes. Ophthalmology 115 (2008) 1859-1868
29. Hypertension Detection and Follow-Up Program Cooperative Group. The Hypertension Detection and Follow-Up Program. Prev Med 5 (1976) 207-215
30. Early Treatment of Diabetic Retinopathy Study Research Group (ETDRS). Manual of Operations (1985), National Technical Information Service, Springfield, VA 101-119 Accession no. PB85-223006
31. Early Treatment Diabetic of Retinopathy Study Research Group. Manual of Operations (1985), National Technical Information Service, Springfield, VA 207-243 Accession no. PB85-223006
32. Moss S.E., Klein R., Klein B.E., et al. Methodologic considerations in measuring glycosylated hemoglobin in epidemiologic studies. J Clin Epidemiol 41 (1988) 645-649
33. Klein R., and Moss S. A comparison of the study populations in the Diabetes Control and Complications Trial and the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Arch Intern Med 155 (1995) 745-754
34. Klein R., Klein B.E., Magli Y.L., et al. An alternative method of grading diabetic retinopathy. Ophthalmology 93 (1986) 1183-1187
35. Early Treatment Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs-an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology 98 suppl (1991) 786-806
36. Early Treatment Diabetic Retinopathy Study Research Group. Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology 98 suppl (1991) 823-833
37. Klein B.E., Davis M.D., Segal P., et al. Diabetic retinopathy: assessment of severity and progression. Ophthalmology 91 (1984) 10-17
38. Gooley T.A., Leisenring W., Crowley J., and Storer B.E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat Med 18 (1999) 695-706
39. Allison P.D. Estimating Cox regression Model with PROC PHREG. In: Whatley J. (Ed). Survival Analysis using the SAS System: A Practical Guide (1995), SAS Institute Inc, Cary, NC 138-150
40. Hirai F.E., Knudtson M.D., Klein B.E., and Klein R. Clinically significant macular edema and survival in type 1 and type 2 diabetes. Am J Ophthalmol 145 (2008) 700-706
41. Roy M.S., and Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol 124 (2006) 1297-1306
42. West K.M., Erdreich L.J., and Stober J.A. A detailed study of risk factors for retinopathy and nephropathy in diabetes. Diabetes 29 (1980) 501-508
43. Knuiman M.W., Welborn T.A., McCann V.J., et al. Prevalence of diabetic complications in relation to risk factors. Diabetes 35 (1986) 1332-1339
44. Jerneld B. Prevalence of diabetic retinopathy: a population study from the Swedish island of Gotland. Acta Ophthalmol Suppl 188 (1988) 3-32
45. Kostraba J.N., Klein R., Dorman J.S., et al. The Epidemiology of Diabetes Complications Study. IV. Correlates of diabetic background and proliferative retinopathy. Am J Epidemiol 133 (1991) 381-391
46. Cruickshanks K.J., Ritter L.L., Klein R., and Moss S.E. The association of microalbuminuria with diabetic retinopathy: the Wisconsin Epidemiologic Study of Diabetic Retinopathy. Ophthalmology 100 (1993) 862-867
47. Klein R., Moss S.E., and Klein B.E. Is gross proteinuria a risk factor for the incidence of proliferative diabetic retinopathy?. Ophthalmology 100 (1993) 1140-1146
48. Romero P., Baget M., Mendez I., et al. Diabetic macular edema and its relationship to renal microangiopathy: a sample of type I diabetes mellitus patients in a 15-year follow-up study. J Diabetes Complications 21 (2007) 172-180
49. Goldsmith J.R., and Landaw S.A. Carbon monoxide and human health. Science 162 (1968) 1352-1359
50. Hawkins R.I. Smoking, platelets and thrombosis. Nature 236 (1972) 450-452
51. Yanbaeva D.G., Dentener M.A., Creutzberg E.C., et al. Systemic effects of smoking. Chest 131 (2007) 1557-1566
52. Adamis A.P. Is diabetic retinopathy an inflammatory disease?. Br J Ophthalmol 86 (2002) 363-365
53. Klein R., Klein B.E., and Davis M.D. Is cigarette smoking associated with diabetic retinopathy?. Am J Epidemiol 118 (1983) 228-238
54. Moss S.E., Klein R., and Klein B.E. Association of cigarette smoking with diabetic retinopathy. Diabetes Care 14 (1991) 119-126
55. Moss S.E., Klein R., and Klein B.E. Cigarette smoking and ten-year progression of diabetic retinopathy. Ophthalmology 103 (1996) 1438-1442